Anaphylactic Shock
Immunotherapy of hypersensitivity to hymenoptera venom is reviewed
Published in Vaccine Weekly, December 28th, 2005
"Insect sting allergy is a common condition with a risk of life-threatening anaphylaxis. After a severe reaction, the fear of being re-stung can significantly reduce quality of life. Venom immunotherapy (VIT) is a highly effective treatment of the underlying type I-sensitization. [Our] review addresses the mechanisms of immune modulation by VIT and outlines current clinical application," investigators in Germany report.
"Although highly effective in the majority of patients, VIT fails in a few individuals," said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-12-28)
More Articles from Vaccine Weekly
- Malaria Vaccine Development
Nasal immunization with vaccine candidate prevents P. falciparum infection - Plague Vaccine
Vaccine induces cell-mediated protection against Yersinia pestis - Pneumonia Vaccine
Age-related changes occur in light-chain gene usage in response to pneumococcal polysaccharides - Vaccine Development
Vaccine development for immunosuppressed may be possible - Vaccine Vectors
Cross-species transfer of viruses has implications for live-virus vaccines - Adenovirus Vector
Innate immune response to adenovirus is reviewed - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
